Acquiring Company
NANO Nuclear Energy
Acquired Company
RADNOSTIX
Description
Radnostix has entered into a definitive agreement to divest its DUF6 and fluorine assets to NANO Nuclear Energy for approximately $13.5 million. The transaction includes a U.S. NRC license and patented technology for nuclear fuel processing. Closing is anticipated within 90 to 120 days, subject to requisite approvals. This sale allows Radnostix to focus on its core radioisotope technologies.
Fundz sees it the moment NANO Nuclear Energy makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired RADNOSTIX?
RADNOSTIX was acquired by NANO Nuclear Energy, based in New York. The deal was reported on October 1, 2026. NANO Nuclear Energy Inc. is an emerging vertically integrated microreactor and advanced nuclear technology company, led by a world-class nuclear engineering team, developing portable clean energy solutions. NANO Nuclear Energy is publicly traded (NNE) and operates in Other.
When did NANO Nuclear Energy acquire RADNOSTIX?
NANO Nuclear Energy's acquisition of RADNOSTIX was reported on October 1, 2026. Radnostix has entered into a definitive agreement to divest its DUF6 and fluorine assets to NANO Nuclear Energy for approximately $13.5 million. The transaction includes a U.S. NRC license and patented technology for nuclear fuel processing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does RADNOSTIX do?
RADNOSTIX, INC. is a technology company specializing in innovative solutions in the healthcare sector. The company focuses on developing advanced systems and software to improve patient outcomes and enhance medical technologies. It is publicly traded (INIS), operating in Information Technology, and is based in Idaho Falls.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.